ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$EOLS:NASDAQ · Evolus Inc - US

Aesthetic neurotoxin (Jeuveau) maker

Sector: health

Conviction from: NASDAQCitrini

52-week range: 3.868.43

2 tracked filer(s) hold this · 2 opened, 0 added, 0 trimmed in 30-JUN-2026

Aggregate 13FScore 72 — mean of 2 scored holder(s) · buyers (new/add) avg 72. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor63New buy31,547$218,9360.0%
Steve Cohen / Point7280New buy1,508,518$10,469,1150.0%

Beyond 13F — activists, insiders, politicians & research

Citrini Research coverage report library →

ReportDateStance
#104 — State of the Themes: Long GOOGL, Asian Outperformance and the Age of Virality2025-08-18LONG
#102 — GLP-1s: The Second Serving - Revisiting our GLP-1 Basket2025-07-24LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.